Concepedia

Avi B. Markowitz

AB

21

Publications

1.4K

Citations

17

H-Index

1985

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Medical Branch at Galveston

Sunnybrook Health Science Centre

Amgen (United States)

Hôtel-Dieu de Québec

Avi B. Markowitz is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and health sciences.

ORCID

Top concepts

Publications per year

1985–2021

21

Publications

21

A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma.

Janice P. Dutcher, Stephen P. Creekmore, Geoffrey R. Weiss et al. · Journal of Clinical Oncology · 1989 · 236 citations

, , +18

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.

Richard Pazdur, Yvonne Lassere, Verna A. Rhodes et al. · Journal of Clinical Oncology · 1994 · 206 citations

Phase II Trial of Weekly Paclitaxel in Patients With Previously Treated Advanced Urothelial Cancer

David J. Vaughn, Catherine M. Broome, Maha Hussain et al. · Journal of Clinical Oncology · 2002 · 193 citations

, , +12

Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial

Michael Henke, A. Fortin, Heikki Minn et al. · The Lancet Oncology · 2015 · 161 citations

, , +10

Collecting Duct Carcinoma of the Kidney

Meletios Α. Dimopoulos, C. Logothetis, Avi B. Markowitz et al. · British Journal of Urology · 1993 · 139 citations

Rows per page

1–5 of 21